Efficacy of Combination Chemotherapy for Treatment of Gastrointestinal Lymphoma in Dogs
Authors:
- K.M. RassnickKRK.M. Rassnick
- A.S. MooreAMA.S. Moore
- K.E. CollisterKCK.E. Collister
- N.C. NorthrupNNN.C. Northrup
- O. KristalOKO. Kristal
- J.D. ChretinJCJ.D. Chretin
- D.B. BaileyDBD.B. Bailey
- 1 March 2009
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 23 (2) , 317-322
Abstract
Background: Chemotherapy for multicentric canine lymphoma has favorable results. The gastrointestinal (GI) tract is the most common extranodal site of canine lymphoma, but there have been no prospective studies to determine outcome when dogs with GI lymphoma are treated with chemotherapy. Hypothesis: Treatment with a multiagent chemotherapy protocol is associated with a poor outcome in dogs with GI lymphoma. Animals: Eighteen dogs with histologically confirmed GI lymphoma. Methods: Prospective clinical trial in which dogs with GI lymphoma were treated with a 20-week combination chemotherapy protocol consisting of induction and consolidation phases. Results: Thirteen dogs had primary GI lymphoma and 5 had multicentric lymphoma with GI involvement. The majority of the lymphomas (63%) were of T-cell origin. Overall remission rate was 56%; 9 dogs achieved a complete remission for a median of 86 days (range, 22–420 days) and 1 dog achieved a partial remission for 26 days. Overall median survival time was 77 days (range, 6–700 days). Dogs that failed to achieve a remission (10 versus 117 days; P= .002) or had diarrhea at initial presentation (70 versus 700 days; P < .001) had shorter survival times. Conclusion and Clinical Importance: The response and survival of dogs with GI lymphoma treated with multiagent chemotherapy is poor but long-term survival is possible.Keywords
This publication has 20 references indexed in Scilit:
- Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphomaJournal of the American Veterinary Medical Association, 2008
- Stage Migration in Dogs with LymphomaJournal of Veterinary Internal Medicine, 2007
- Treatment of Dogs with Lymphoma Using a 12-Week, Maintenance-Free Combination Chemotherapy ProtocolJournal of Veterinary Internal Medicine, 2006
- Veterinary co‐operative oncology group – common terminology criteria for adverse events (VCOG‐CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0Veterinary and Comparative Oncology, 2004
- Characterization of Lymphocytes in Canine Gastrointestinal LymphomaVeterinary Pathology, 2004
- A combination chemotherapy protocol with MOPP and CCNU consolidation (Tufts VELCAP‐SC) for the treatment of canine lymphomaVeterinary and Comparative Oncology, 2003
- Tumors of the Hemolymphatic System2002
- Primary Epitheliotropic Alimentary T-cell Lymphoma with Hepatic Involvement in a DogVeterinary Pathology, 1996
- Evaluation of Prognostic Factors and Sequential Combination Chemotherapy With Doxorubicin for Canine LymphomaJournal of Veterinary Internal Medicine, 1993
- Gastrointestinal Lymphoma in 20 DogsJournal of Veterinary Internal Medicine, 1989